» Articles » PMID: 39777865

The MR1/MAIT Cell Axis Enhances Dystrophic Neurite Development in Alzheimer's Disease

Overview
Date 2025 Jan 8
PMID 39777865
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Plaques are a hallmark feature of Alzheimer's disease (AD). We found that the loss of mucosal-associated invariant T (MAIT) cells and their antigen-presenting molecule MR1 caused a delay in plaque pathology development in AD mouse models. However, it remains unknown how this axis is impacting dystrophic neurites.

Methods: Brain tissue from 5XFAD mice and those that are MR1 deficient (MR1 KO), were analyzed for dystrophic neurites, amyloid plaques, and synapses via immunofluorescence, RNA sequencing, enzyme-linked immunosorbent assay, and western blot.

Results: In 8-month-old 5XFAD/MR1 KO mice, there was reduced expression of lysosomal-associated membrane protein 1, ubiquitin, and n-terminal amyloid precursor protein in the hippocampus compared to 5XFAD mice (P < 0.05). 5XFAD/MR1 KO mice also had less insoluble amyloid beta 40 (P < 0.001) and higher levels of postsynaptic density protein 95 (P < 0.01) in the hippocampus.

Discussion: Our data contribute additional mechanistic insight into the detrimental role of the MR1/MAIT cell axis in AD pathology development.

Highlights: 5XFAD mice lacking the innate immune MR1/MAIT (mucosal-associated invariant T) cell axis (5XFAD/MR1 KO) have reduced numbers of dystrophic neurite markers in the hippocampus at 8 months of age. Hippocampal tissue transcriptional analyses showed reduced expression of genes encoding classical dystrophic neurite markers in 5XFAD/MR1 KO mice. 5XFAD/MR1 KO mice had less insoluble amyloid beta 40 and increased levels of the post-synaptic marker, postsynaptic density protein 95, in the hippocampus than did MR1+ 5XFAD mice.

Citing Articles

The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease.

Wyatt-Johnson S, Ackley S, Warren J, Priya R, Wan J, Liu S Alzheimers Dement. 2025; 21(2):e14480.

PMID: 39777865 PMC: 11848147. DOI: 10.1002/alz.14480.

References
1.
Wyatt-Johnson S, Afify R, Brutkiewicz R . The immune system in neurological diseases: What innate-like T cells have to say. J Allergy Clin Immunol. 2024; 153(4):913-923. PMC: 10999338. DOI: 10.1016/j.jaci.2024.02.003. View

2.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

3.
Wyatt-Johnson S, Ackley S, Warren J, Priya R, Wan J, Liu S . The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease. Alzheimers Dement. 2025; 21(2):e14480. PMC: 11848147. DOI: 10.1002/alz.14480. View

4.
Wyatt-Johnson S, Sommer A, Shim K, Brewster A . Suppression of Microgliosis With the Colony-Stimulating Factor 1 Receptor Inhibitor PLX3397 Does Not Attenuate Memory Defects During Epileptogenesis in the Rat. Front Neurol. 2021; 12:651096. PMC: 8209304. DOI: 10.3389/fneur.2021.651096. View

5.
. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7(2):e105-e125. PMC: 8810394. DOI: 10.1016/S2468-2667(21)00249-8. View